Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
15-19 June, 2025
Not Confirmed
Not Confirmed
15-19 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
15-19 June, 2025
Industry Trade Show
Not Confirmed
15-19 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520245987/en/Fresenius-Kabi-Introduces-Epinephrine-Injection-USP-in-30-mg-per-30-mL-Multi-Dose-Vials
19 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250519113313/en/FDA-Grants-Interchangeable-Designation-to-Fresenius-Kabis-biosimilar-Otulfi-ustekinumab-aauz
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505699828/en/BioLife-Plasma-Services-Introduces-the-New-Fresenius-Kabi-Adaptive-Nomogram-Across-its-U.S.-Network-of-Plasma-Donation-Centers
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428100791/en/CMS-Grants-Fresenius-Kabi-Permanent-Product-Specific-Q-Code-for-Otulfi-ustekinumab-aauz
03 Mar 2025
// BUSINESSWIRE
01 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/blue-shield-of-california-slashes-cost-of-worlds-best-selling-drug-302263309.html
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5201
Submission : 1984-01-03
Status : Inactive
Type : II
Excipients
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9014
Submission : 1991-03-13
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9014
Submission : 1991-03-13
Status : Active
Type : IV
Excipients Web Link
Inspections and registrations
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-09-26
City : Friedberg
State :
Country/Area : DE
Zip :
District : ORA
Center : CDER
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2014-09-26
ABOUT THIS PAGE
Fresenius Kabi AG is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of Docetaxel bulk with JDMF offered by Fresenius Kabi AG
Find a price of Gemcitabine bulk with JDMF offered by Fresenius Kabi AG
Find a price of Irinotecan Hydrochloride bulk with JDMF offered by Fresenius Kabi AG
Find a price of Ampicillin Sodium bulk offered by Fresenius Kabi AG
Find a price of Cefalotin sodium Sterile bulk offered by Fresenius Kabi AG
Find a price of Cefatrizine bulk offered by Fresenius Kabi AG
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Fresenius Kabi AG